J. Wolchko | executive |
Edward Dulac | executive |
Michael Yee | analyst |
Bob Valamehr, Ph.D. | executive |
Yigal Nochomovitz | analyst |
Carolina Ibanez-Ventoso | analyst |
Alex Xenakis | analyst |
Yanan Zhu | analyst |
Ethan Markowski | analyst |
Welcome to the Fate Therapeutics First Quarter 2024 Financial Results Conference Call. [Operator Instructions]. This call is being webcast live on the Investors section of FEI's website at fatetherapeutics.com.
As a reminder, today's call is also being recorded.
I would now like to turn -- I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.